EMA Authorised: Trydonis (beclometasone dipropionate;formoterol fumarate dihydrate;glycopyrronium) — Chiesi Farmaceutici S.p.A.

View source ↗

Summary

EMA authorised Trydonis for chronic obstructive pulmonary disease; a fixed-dose triple inhaler containing beclometasone dipropionate, formoterol fumarate dihydr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Beclometasone dipropionate
• Formoterol fumarate dihydrate
• glycopyrronium (glycopyrronium)

Snippet

Status: Authorised. Therapeutic area: Pulmonary Disease, Chronic Obstructive. MAH: Chiesi Farmaceutici S.p.A.. Decision date: 16/03/2026